Metraipolis › archive › dc_e4e55b41dfc4

Cardiac disorders associated with compound long-acting bronchodilators for inhalation: a pharmacovigilance analysis of the FDA adverse event reporting system… — Europe PMC PMID:41878490

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41878490
DOI
10.3389/fcvm.2026.1715192
License (as archived)
solo-consultazione
Archived
2026-11-04T23:59:18.920Z
SHA-256 of the archived text
b18f4ce4939ba3cf63a8242c74cffa4feff371078f34bc2c152d965d6e7b4aa7
Stable URL of this page
https://metraipolis.com/documento/dc_e4e55b41dfc4

How to cite

Cardiac disorders associated with compound long-acting bronchodilators for inhalation: a pharmacovigilance analysis of the FDA adverse event reporting system… — Europe PMC PMID:41878490 — Europe PMC (en), https://europepmc.org/article/MED/41878490 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_e4e55b41dfc4 (Metraipolis archive dc_e4e55b41dfc4, sha256 b18f4ce4939ba3cf63a8242c74cffa4feff371078f34bc2c152d965d6e7b4aa7)
BibTeX
@misc{dce4e55b41dfc4,
  title = {Cardiac disorders associated with compound long-acting bronchodilators for inhalation: a pharmacovigilance analysis of the FDA adverse event reporting system… — Europe PMC PMID:41878490},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41878490},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_e4e55b41dfc4; sha256 b18f4ce4939ba3cf63a8242c74cffa4feff371078f34bc2c152d965d6e7b4aa7},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41878490. Agents can read the archived copy with the MCP tool read_document.